Healthcare

Healthcare

Johnson & Johnson Consumer Health Unveils New Skin Health Research at 2022 American Academy of Dermatology Meeting
25 March 2022
3351
SKILLMAN, N.J., March 25, 2022 – Johnson & Johnson Consumer Inc. will present new research highlighting important advances in the understanding and treatment of skin at the 2022 American Academy of Dermatology (AAD) Meeting, taking pla...
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
23 March 2022
3489
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor modulator in development for the tr...
Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
18 March 2022
3200
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership ...
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
23 February 2022
3610
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agre...
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
15 February 2022
3471
Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) has approved the company’s 20-valent pneumococcal conjugate vaccine (PCV20), which will be marketed in the European Union (EU) under the brand name APEXXNAR. The va...
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
4 February 2022
3323
Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2021, which reflect strong sales driven by robust commercial execution and significant advancement of the company’s pipeline that further progres...
Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program
31 January 2022
3661
Pfizer Inc. (NYSE: PFE) and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy that was being...
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
18 January 2022
3447
Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir...
Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant
30 December 2021
3248
Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a homologous (same vaccine) booster shot of the Johnson & Johnson COVID-19 vaccine (Ad26.COV2....
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
25 December 2021
3051
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Di...
Omeros Completes Sale of OMIDRIA Franchise to Rayner Surgical
23 December 2021
3021
Omeros Corporation (Nasdaq: OMER) today announced that it has completed the sale of OMIDRIA (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group Inc., an affiliate of Rayner Surgical Group Limited. The transaction was...
Moderna announces preliminary booster data and updates strategy to address Omicron variant
20 December 2021
3299
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster candidates at 50...
BeyondSpring pharmaceuticals announces new clinical data confirming plinabulin's fast onset mechanism of action in the prevention of  chemotherapy-induced neutropenia at the 63RD ash annual meeting and exposition
17 December 2021
3145
Beyond Spring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced new data highlighting the mechanism of action o...
New Clinical and Real-World Data Support Use of DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma
11 December 2021
3312
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX® (daratumumab)-based regimens may be able to achieve, including a potential survival be...
UnitedHealthcare Introduces Health Plan Delivering Lower Costs and a Patient-Focused Health Care Experience
2 December 2021
3126
UnitedHealthcare has introduced a new health plan that offers consumers in Southwest Arizona personalized and seamless customer support as well as the opportunity to save up to 15% on premiums. The Doctors Plan of Arizona provides access to quality,...
Johnson & Johnson Discussions to License its COVID-19 Vaccine to Aspen Reach Advanced Stage
30 November 2021
3171
Johnson & Johnson is pleased to reach an advanced stage in its discussions for a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, which is based in South Africa. The parties will continue to work toward a...
Cardinal Health Teams Up with Zipline for Automated, On-Demand Delivery to Retail Pharmacies
17 November 2021
3198
Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery to pharmacies. Cardinal Health will use Zipline’s service for on-demand r...
CVS Health launches first nationwide virtual primary care solution
14 August 2021
3704
Aetna, a CVS Health company (NYSE: CVS), announced an innovative health care solution, Aetna Virtual Primary Care, that reimagines the primary care experience and makes it easier for people to get the health services they need, anytime, anywhere. "T...
Henry Schein Opens Customer Assistance Hotline in Response to the Dixie Fire in Northern California
11 August 2021
3306
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in California that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of ...
Marking the Milestone, Celebrating the Achievement: MSK Kids Hosts 15th Annual Pediatric Convocation
12 June 2021
3313
For the 15th year, MSK today honored the academic achievements of our youngest patients by hosting MSK Kids Convocation - a virtual ceremony to help mark and celebrate the end of their adolescent school years. Almost 40 current and former patients j...

NEW YORK PRESS RELEASES


GlobalNY.biz Press Releases are the latest news from New York companies.
Official press releases of New York companies are regularly published on the resource. You can find out the latest news of enterprises in the corresponding section on the main page. Placing press releases is a traditional and effective way to promote your business. It allows organizations to announce themselves and their products and services to the widest possible audience. In this case, the informational occasion can be anything: attracting people to an event or conference, highlighting new products or personnel appointments. If you set a goal to draw attention to your information, then GlobalNY.biz will become your reliable assistant in this matter. Thanks to the portal, your press release will be seen by reviewers of leading Internet publications, clients and partners.
GlobalNY.biz allows representatives of companies and organizations in New York to independently post a press release when registering on the resource. The most important feature of GlobalNY.biz is that all publications of New York companies fall into the archives and will be available from the search for a long time. You just need to add the press release to the news feed.
GlobalNY.biz offers its customers a subscription service that allows companies to regularly publish press releases on favorable terms. In addition, the business portal makes it possible to more fully tell about the life of the company by adding photos and videos, personas and employee quotes. All information materials have active links and will lead potential customers to your resource.
Alena Potapova

Development Director
Population
8131860793
Died this year
27421823
Born this year
67462538